Mass General Brigham Health Plan is removing Dana-Farber Cancer Institute from its Medicare Advantage network starting October 1. The decision affects roughly 1,000 patients slated for appointments this year, leaving older adults scrambling to switch insurance or find new oncologists amid a broader institutional split in Boston.
Eldon Clingan and the Human Toll of Boston’s Network Cut
Eldon Clingan has trusted the same oncologist at Dana-Farber Cancer Institute for more than two decades. Diagnosed with prostate cancer in 1999, the now 88-year-old retired accountant relies on a specialized medication costing $10,000 a month. That stable routine faces an abrupt end.
Starting October 1, the insurance arm of Mass General Brigham will drop Dana-Farber from its Medicare Advantage network, a change first reported by The Boston Globe. For Clingan and approximately 1,000 other plan members who had or are slated to have appointments at the institute this year, the shift triggers difficult choices.
About 250 of those members are currently undergoing active treatment, including radiation or chemotherapy, according to CBS News. While impacted patients can maintain in-network coverage through a 90-day transition period or until their current treatment plans conclude, anyone wanting to stay at Dana-Farber past the new year must enroll in a different insurance plan.
Financial Squeeze and the Institutional Breakup Behind the Policy
Mass General Brigham Health Plan attributed the network removal to a challenging environment impacting Medicare Advantage plans nationwide
[CBS News]. Jennifer St. Thomas, MGB Health Plan’s senior vice president of commercial and Medicare markets, explained that rising care costs have outpaced federal reimbursements, forcing tough administrative choices [The Boston Globe]. Executives maintain that the insurance division operates separately from the hospital system for legal and business reasons.
Yet the network cut arrives against the backdrop of a very public divorce between the two healthcare giants. Dana-Farber previously announced it would end its long-term partnership with Mass General Brigham in 2028, opting instead to build a new freestanding adult cancer hospital with rival system Beth Israel Lahey Health [The Boston Globe]. The Massachusetts Public Health Council approved Dana-Farber’s application for the $1.7 billion project [CBS News, Hoodline].
Mass General Brigham has responded with its own massive expansion, securing $865.5 million in tax-exempt bond financing and planning a $400 million investment in its own cancer institute. MGB representatives insist the insurance network drop is unrelated to the ongoing clinical separation and realignment among cancer providers in Boston
[CBS News].
“Why would you do that to patients? If you’re trying to be a good health plan, why would you go and say you suddenly can’t have access to the top cancer center in Boston?”
David E. Williams, president of Health Business Group, via The Boston Globe
Navigating Open Enrollment and Alternative Care Options
For policyholders caught in the middle, options are bounded by federal Medicare rules.
Because the exclusion takes effect on October 1, patients wishing to switch plans outside standard periods must navigate federal enrollment guidelines ahead of the national open enrollment window.
Ещё по этой теме
